Physician

Alexander Cox Hadley, MD

According to 2025 Medicare claims, Alexander Hadley, MD (NPI: 1881679215) practices nephrology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is W SCOTT MOORE ET AL PTR (NPI: 1275580854; TIN: 56-1573039) and primary practice location at 27103-7108.

Hadley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 410 traditional Medicare patients, billed 1,243 HCPCS/CPT codes, and received $124,032 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,139 prescription claims across 358 beneficiaries totaling $346,474 in drug costs, led by Jardiance (Empagliflozin). DME data shows 279 claims. Open Payments data shows 81 records totaling $1,455. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $218,488 to $124,032. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $293,234 and ending at $346,474. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,365 to $2,604.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	665	6,851	$218,488
2016	623	2,102	$193,134
2017	600	2,073	$191,491
2018	624	1,667	$187,886
2019	740	2,622	$234,452
2020	662	3,030	$224,929
2021	546	1,884	$203,473
2022	468	1,203	$145,364
2023	427	1,067	$133,103
2024	410	1,243	$124,032

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	266	2,275	$293,234
2016	226	2,496	$426,683
2017	233	2,244	$304,515
2018	247	2,074	$186,790
2019	304	2,091	$174,307
2020	266	1,740	$160,730
2021	268	1,607	$209,576
2022	299	1,811	$243,093
2023	313	1,913	$303,234
2024	358	2,139	$346,474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	474	$55,781
2016	23	499	$46,352
2017	38	570	$47,918
2018	42	541	$47,882
2019	59	554	$43,509
2020	61	538	$28,408
2021	12	455	$42,876
2022	11	453	$43,868
2023	N/R	297	$23,108
2024	N/R	279	$21,030

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	151	196	$262
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	64	204	$58
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	142	280	$53
90935	Hemodialysis procedure with physician evaluation	50	118	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	114	144	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	120	6,780	$131,280
Farxiga	Dapagliflozin Propanediol	86	3,991	$74,879
Lokelma	Sodium Zirconium Cyclosilicate	27	903	$20,456
Veltassa	Patiromer Calcium Sorbitex	22	912	$16,472
Sevelamer Carbonate	Sevelamer Carbonate	51	2,130	$14,805

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	21	$16,673
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	44	$1,991
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	57	$941
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	81	$941
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	34	$458

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$1,455	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Cox Hadley, MD?

Tedicare shows public-source Medicare data for Alexander Cox Hadley, MD (NPI 1881679215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Cox Hadley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Cox Hadley, MD?

Alexander Cox Hadley, MD is linked to W SCOTT MOORE ET AL PTR (billing NPI 1275580854) in the available physician profile data.

Does Alexander Cox Hadley, MD have Open Payments data?

Alexander Cox Hadley, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.